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A B S T R A C T
Brain and muscle glycogen are generally thought to function as local glucose reserves, for use during transient
mismatches between glucose supply and demand. However, quantitative measures show that glucose supply is
likely never rate-limiting for energy metabolism in either brain or muscle under physiological conditions. These
tissues nevertheless do utilize glycogen during increased energy demand, despite the availability of free glucose,
and despite the ATP cost of cycling glucose through glycogen polymer. This seemingly wasteful process can be
explained by considering the effect of glycogenolysis on the amount of energy obtained from ATP (ΔG’ATP). The
amount of energy obtained from ATP is reduced by elevations in inorganic phosphate (Pi). Glycogen utilization
sequesters Pi in the glycogen phosphorylase reaction and in downstream phosphorylated glycolytic inter-
mediates, thereby buffering Pi elevations and maximizing energy yield at sites of rapid ATP consumption. This
thermodynamic effect of glycogen may be particularly important in the narrow, spatially constrained astrocyte
processes that ensheath neuronal synapses and in cells such as astrocytes and myocytes that release Pi from
phosphocreatine during energy demand. The thermodynamic effect may also explain glycolytic super-com-
pensation in brain when glycogen is not available, and aspects of exercise physiology in muscle glycogen
phosphorylase deficiency (McArdle disease).
1. Introduction
Large, rapid increases in local energy demand, correlating with bursts of
neuronal activity, are a defining feature of brain energy metabolism. The
metabolic demands posed by these increases are met in part by increases in
local blood flow. However, changes in local blood flow occur on a time
scale that is orders of magnitude slower than changes in local brain activity,
resulting in transient mismatches between local energy demand and sub-
strate delivery. These mismatches are accommodated several ways, in-
cluding increased ATP production from local glucose and phosphocreatine
reserves (see Text Box). Skeletal muscle likewise exhibits large, rapid fluc-
tuations in energy demand associated with bursts of activity, and like brain,
muscle responds to these fluctuations with a combination of blood flow and
metabolic responses. Among these metabolic responses is rapid utilization
of glycogen.
Glycogen is stored in cells as granules comprised of highly branched
glucose polymer (Fig. 1). Both brain and muscle contain millimolar
concentrations of glucose stored as glycogen, and in both tissues gly-
cogen utilization is time-linked to increases in energy demand. It is thus
widely assumed that glycogen in these tissues functions to buffer mis-
matches between glucose supply and demand. However, this concept
does not account for several fundamental aspects of glycogen metabo-
lism. Glycogen utilization occurs continuously in normal brain, despite
the fact that use of glucose derived from glycogen entails a net ATP cost
relative to use of free glucose. In skeletal muscle, glycogen is required
for rapid and efficient contraction even when free glucose is available;
and in both brain and muscle, local glucose concentrations rarely if ever
fall to levels that could be rate-limiting for energy metabolism; instead,
glycogen is consumed despite an excess of usable glucose.
Prevailing concepts of glycogen metabolism also ascribe differing
and somewhat conflicting roles for glycogen in muscle and brain.
Muscle glycogen is considered a source of glucose for the myocytes
themselves, whereas astrocyte glycogen is instead widely viewed as a
source of lactate that is exported to neurons for use as an energy me-
tabolite. However, lactate cannot be used for ATP production if oxygen
availability is insufficient, as is the case whenever glucose availability is
insufficient (excepting profound hypoglycemia). Moreover, quantita-
tive studies indicate that most lactate derived from astrocyte glycogen
is released to the blood stream (Dienel, 2012, 2019), in the same
manner as lactate generated from exercising muscle. Also as in muscle,
there is no evidence that glucose consumption in brain can outstrip
normal glucose supply under physiological conditions. These
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interleaving considerations warrant a reassessment of the basic ob-
servations and assumptions pertaining to glycogen metabolism in both
brain and muscle. This perspective will review the bioenergetics of
glycogen metabolism, identify conflicts between current concepts and
experimental data, and argue that the primary function of glycogen is
the same in both brain and skeletal muscle: to maintain maximal energy
yield from ATP.
The capacity of cells to carry out energy-dependent processes de-
pends not only on their capacity to maintain ATP concentrations, but
also to maintain the amount of energy obtained from ATP hydrolysis to
ADP and Pi. This energy amount, termed ΔG’ATP, is not a constant but is
instead influenced by the ratios of the reactants and products of the ATP
hydrolysis reaction. In simplified form, ΔG’ATP varies in proportion to
the ratio [ADP]∙[Pi] : [ATP]. As this ratio rises the ΔG’ATP becomes
smaller, and at the extreme condition no energy can be obtained from
ATP regardless of ATP abundance (Nicholls and Ferguson, 2013).
Crucially, the first step of glycogen mobilization subtracts inorganic
phosphate (Pi) from the cytosol, thereby preserving ΔG’ATP. This ther-
modynamic function of glycogenolysis is likely particularly important
for cells that that intermittently consume phosphocreatine (which in-
directly generates free Pi), and for cells such as astrocytes in which ATP
hydrolysis occurs in extremely narrow, confined spaces.
2. Regulation and bioenergetics of glycogen metabolism
Glycogen concentrations vary considerably across cell types, being
highest in liver, brain and skeletal muscle, and much lower in smooth
muscle and other tissues (Table 1). Liver has a special role as a systemic
glycogen storage depot. To this end, hepatocytes express glucose-6-
phosphatase for generating exportable free glucose from glycogen-de-
rived glucose-6-phosphate. Brain and muscle have only negligible ex-
pression of glucose-6-phosphatase (Dringen et al., 1993; Gamberucci
et al., 1996), and correspondingly do not have a role analogous to he-
patocytes as a source of free glucose for use by other cells.
As illustrated in Fig. 1, the glucose residues in glycogen are joined as
linear chains by α-1,4-glycosidic bonds, with branch points formed by
α-1,6-glycosidic bonds approximately every 10–14 glucose residues
(Calder, 1991). Glycogen synthesis requires uridine diphosphate glu-
cose (UDP-glucose) as a substrate, which is produced from uridine tri-
phosphate and glucose-1-phosphate by UDP-glucose pyropho-
sphorylase. The α-1,6-glycosidic branch points are subsequently
produced by glycogen branching enzyme (1,4-α-glucan-branching en-
zyme). Glycogenolysis, by which glucose residues are detached from
glycogen, is mediated by glycogen phosphorylase, which hydrolyzes
glucose residues at α-1,4 linkage points to generate glucose-1-phos-
phate. Glycogen debranching enzyme acts at the α-1,6 branch points to
provide a linear substrate for glycogen phosphorylase (Nakayama et al.,
2001).
Mammals express three isoforms of glycogen phosphorylase: a liver
isoform, a muscle isoform and a brain isoform, each termed by the
tissue in which it is predominately expressed. Astrocytes contain both
the brain isoform (PGYB) and the muscle isoform (PGYM), and low
levels of the brain isoform also detectable in some neurons (Pfeiffer-
Guglielmi et al., 2003). The isoforms differ in response to various reg-
ulatory influences (Mathieu et al., 2017). Glycogen phosphorylase is
regulated by changes in energy state through allosteric effects of ATP
and glucose-6-phosphate, which slow enzymatic activity, and AMP,
which accelerates activity. Glycogen phosphorylase is also regulated by
Text Box:
Cellular responses to graded energy demands: glycogen, phosphocreatine, and adenylate kinase.
Relationships between energy demand and energy supply can be divided into three stages.
1 At rest or moderate exercise, glycolysis and mitochondrial oxidative phosphorylation together regenerate ATP at a rate sufficient to meet
demand, and there is no net increase in ADP or Pi concentrations. Mitochondrial oxidative phosphorylation is fueled by several substrates,
including lipids, amino acids, ketone bodies, and the lactate or pyruvate generated by glycolysis.
2 With increasing energy demand, a point is reached at which the rate of mitochondrial oxidative phosphorylation is maximal, but the rate of
glycolytic ATP production can further increase. The excess pyruvate resulting from the mismatch between glycolytic and oxidative me-
tabolism is converted to lactate in order to regenerate the NAD+ consumed by glycolysis, and the lactate is either exported to the blood
stream or used locally, after conversion back to pyruvate, when energy demand is lessened. Glycolysis can be fueled either by glucose or
glycogen stores, but there is a net cost of one ATP per glucose moiety cycled on and off of glycogen polymer (Fig. 2).
3 With extreme or very rapid onset energy demand, ATP consumption outstrips the maximal rate that ATP can be produced even with maximal
glycolytic flux. Under these conditions, cells consume phosphocreatine (PCr) through the creatine kinase reaction:
PCr + ADP ↔ ATP + Cr (A.1)
This reaction both increases ATP and lowers ADP concentrations, but the relative effect on ADP is far greater because cytosolic
ATP> >ADP. All cell types also use PCr to facilitate intracellular dispersion of ATP and ADP equivalents (Wallimann, 1994), but skeletal
muscle and brain uniquely contain high levels of cytosolic PCr to permit a net consumption of PCr during intervals of rapid ATP hydrolysis.
During net PCr consumption, there is an equimolar production of Pi, as the ATP is cycled back to ADP.
(A.2)
Cells experiencing extreme levels of energy demand also employ the adenylate kinase reaction:
ADP + ADP → ATP + AMP (A.3)
This reaction likewise has a far greater relative effect on lowering ADP levels than on increasing ATP levels. The adenylate kinase pathway
can be utilized for only limited intervals because the excess AMP it generates is rapidly degraded to inosine and ammonia, consequently
depleting the total adenylate pool (ATP + ADP + AMP).
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glycogen phosphorylase kinase, which is in turn responsive to several
signaling pathways. For example, stimulation of ß-adrenergic receptors
activates glycogen phosphorylase kinase through the cAMP / protein
kinase A pathway. This provides a mechanism for “anticipatory” gly-
cogen mobilization prior to any actual perturbation in cellular energy
state. Glycogen phosphorylase kinase can also be activated by Ca2+
binding to its calmodulin subunit, a mechanism particularly important
in skeletal muscle, where contraction is initiated by release of Ca2+
from the sarcoplasmic reticulum.
The immediate product of glycogen phosphorylase is glucose-1-
phosphate, which exists in equilibrium with glucose-6-phosphate.
Glucose-6-phosphate is also produced from free glucose in the initial
step of glycolysis (Fig. 2), but there are significant bioenergetic differ-
ences between these two pathways. First, there is a net cost of one ATP
Fig. 1. Schematic two-dimensional cross-sectional view of glycogen. A core protein of glycogenin is surrounded by branches of glucose units. The entire globular
granule may contain up to 30,000 glucose units. The individual glucose moieties of glycogen are linked by α-1,4-glycosidic bonds, with α-1,6-glycosidic branch
points every 10 - 14 glucose residues. The exposed ends of all glycogen chains are non-reducing. Image from (Haggstrom, 2014).
Table 1
Tissue glycogen concentrations.
Tissue Glycogen (mg / g) Citation
Liver 29.02± 2.40 (Vissing et al., 1989)
Liver 41.39± 5.28* (Kusunoki et al., 2002)
Muscle (gastrocnemius-plantaris-soleus complex) 5.70± 0.24a (Baker et al., 2005)
Muscle (white gastrocnemius) 6.73± 0.16 (Vissing et al., 1989)
Brain (cortex) 2.01± 0.26 (Cruz and Dienel, 2002)
Brain (whole brain) 1.98± 0.20 (Oe et al., 2016)
Heart 4.33± 0.32 (Vissing et al., 1989)
Heart 3.99± 0.22 (Conlee et al., 1989)
Kidney 0.06± 0.01 (Khandelwal et al., 1979)
Kidney 0.03± 0.01* (Nannipieri et al., 2001)
Data are from adult rat or mouse under rest, non-fasted conditions. Values are means± SEM or means± SD (*). Glycogen in brain is
restricted primarily to astrocytes, which comprise less than 25 % of brain volume (Gundersen et al., 2015). The glycogen content within
astrocytes is thus roughly 4 times the measured brain value.
aReported as mmol / kg dry weight; converted here using 76 % as the water content of muscle.
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for each glucose residue shuttled onto and off glycogen polymer, as two
ATP are consumed in forming UDP-glucose and only one ATP equiva-
lent is regained with the formation of glucose-1-phosphate (Fig. 2).
Second, glycogen metabolism to glucose-1-phosphate has the im-
mediate effect of removing Pi from the cytosol, whereas formation of
glucose-6-phosphate from free glucose does not. These two differences
have fundamental implications for the functions of brain and muscle
glycogen.
2.1. Special aspects of glycogen metabolism in brain
The importance of glycogen in brain function is less widely re-
cognized than its role in muscle. Astrocytes contain most of the gly-
cogen in brain, with much smaller amounts also detectable in me-
ningeal cells, endothelial cells, and other cell types (Cali et al., 2016;
Cavalcante et al., 1996; Ibrahim, 1975; Koizumi, 1974). Neurons con-
tain appreciable amounts of glycogen during development, but this falls
to low (but non-zero) levels in the mature brain except in certain
brainstem neurons (Borke and Nau, 1984; Oe et al., 2016; Saez et al.,
2014). Astrocytes maintain homeostasis of brain extracellular space
through active, energy-dependent processes (Kettenmann and Ransom,
2012). They form a syncytium through gap junctions, and extend in-
numerable fine processes that function independently of one another as
metabolic microdomains (Grosche et al., 1999). Electron microscopy
identifies glycogen granules throughout astrocyte cell bodies and pro-
cesses, particularly near axonal boutons and dendritic spines (Cali et al.,
2016). After accounting for the fact that almost all brain glycogen is in
astrocytes, and astrocytes comprise less than 25 % of brain volume
(Gundersen et al., 2015), the estimated glycogen concentration in as-
trocytes is roughly comparable to that in skeletal muscle (Table 1).
Glucose is by far the primary energy substrate used by brain, and
glucose metabolites liberated from astrocyte glycogen can support
neuronal survival for limited periods of time during brain ischemia or
profound hypoglycemia (Kilic et al., 2018; Seidel and Shuttleworth,
2011; Suh et al., 2007; Swanson and Choi, 1993; Swanson et al., 1990;
Wender et al., 2000). However, several factors indicate that this is not
the primary function of brain glycogen. These factors include con-
tinuous turnover of brain glycogen during normal brain activity, sup-
pression of glycogen turnover during anesthesia or hibernation
(Swanson, 1992), the location of most glycogen in astrocytes rather
than neurons, and the complex neuromodulatory influences that reg-
ulate astrocyte glycogen metabolism. Brain glycogen turnover (utili-
zation and re-synthesis) accelerates in response to local neuronal ac-
tivity (Swanson et al., 1992; Watanabe and Passonneau, 1973) to rates
that can match or exceed activity -induced increases in local utilization
of free glucose (Dienel, 2019; Shulman et al., 2001). Glycogen turnover
is stimulated by neurotransmitters and other signaling molecules in-
cluding serotonin, norepinephrine, arachidonic acid, glutamate, and K+
(Magistretti, 1988; Quach et al., 1982; Subbarao et al., 1995; Walls
et al., 2009).
Transgenic mice lacking brain glycogen synthase further demon-
strate a role for glycogen metabolism in normal brain function. These
mice are overtly normal, but have increased susceptibility to hippo-
campal seizures following the administration of kainate or stimulation
of Schaffer collaterals (Lopez-Ramos et al., 2015). These mice also ex-
hibit impaired synaptic plasticity, as evidenced by decreased long-term
potentiation in the hippocampus and impairment in an associative
learning task (Duran et al., 2013). Studies using inhibitors of glycogen
phosphorylase likewise suggest a role for glycogen in memory con-
solidation (Gibbs et al., 2006; Gibbs and Hutchinson, 2012; Gibbs et al.,
2007; Newman et al., 2011). Electrophysiology recordings from ex vivo
optic nerve and corpus callosum show that the capacity of axons to
Fig. 2. Bioenergetics and regulation of glycogen metabolism. Glycogen synthase extends an existing glucosan chain of α-1,4-glycosidic linkages using UDP-glucose as
substrate. Glycogen branching enzyme subsequently forms α-1,6-glycosidic bonds to create branch points. Glycogenolysis is mediated by debranching enzyme and
glycogen phosphorylase. Glycogen phosphorylase is regulated allosterically in response to neurotransmitters and hormones, by changes in energy metabolites (AMP,
glucose-6-phosphate, and others), and by second messengers such as cAMP. The immediate product of glycogen phosphorylase is glucose-1-phosphate, which is freely
converted to glucose-6-phosphate. Hepatocytes (but not other cell types) can rapidly dephosphorylate glucose-6-phosphate to generate free glucose for export. There
is a net cost of one ATP per molecule of glucose-6-phosphate that is cycled onto and off of the glycogen polymer, as 2 ATP equivalents are consumed in forming UDP-
glucose from glucose-1-phosphate and only 1 ATP equivalent is gained back at the formation of glucose-1-phosphate at the glycogen phosphorylase step. The
formation of glucose-1-phosphate from glycogen (but not from glucose) removes Pi from the cytosol.
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maintain conductance during high frequency stimulation varies in
proportion to astrocyte glycogen content in these structures (Brown
et al., 2012, 2005; Wender et al., 2000). These and other studies also
suggest that lactate derived from astrocyte glycogen can be metabolized
by neurons (Dringen et al., 1993; Tekkok et al., 2005; Tsacopoulos and
Magistretti, 1996); however, lactate metabolism is ubiquitous (Veech,
1991), and there remains controversy as to whether this is a significant
mechanism by which astrocytes support neuronal function in vivo
(Dienel, 2019; Dienel and Cruz, 2004). It should also be noted that
lactate cannot normally serve as an energy metabolite under conditions
under which local blood delivery of glucose insufficient. This is because
lactate must be metabolized oxidatively, and blood normally carries a
considerable excess of glucose over extractable oxygen (after ac-
counting for the 6:1 ratio of oxygen : glucose required for oxidative
glucose metabolism). Accordingly, blood flow that is insufficient to
provide adequate glucose will also be insufficient to provide oxygen
required for lactate metabolism.
3. Current concepts of brain glycogen function
The energetic cost of shuttling glucose on and off glycogen (1 ATP
per glucose moiety) strictly limits the conditions under which there can
be an advantage to utilizing glycogen stores over free glucose.
Accordingly, current views presume that glycogen is utilized only when
glucose supply is insufficient. The concentration of glucose in blood
does not fall near values affecting brain function under physiological
conditions, but it has been proposed that glucose supply to locally ac-
tivated regions of brain might become transiently insufficient during
the brief interval between onset of local neuronal activity and sub-
sequent increase in local blood flow (Swanson, 1992; Swanson et al.,
1992). This idea was formally developed by Shulman and colleagues as
the “glycogen shunt” hypothesis, to explain changes in the ratio of
glucose : oxygen utilization observed during local brain activation
(Shulman et al., 2001). A related idea proposes that astrocyte glyco-
genolysis occurs pre-emptively near active neurons to prevent reduc-
tions in neuronal access to extracellular glucose (Dienel and Cruz, 2015;
DiNuzzo, 2019; DiNuzzo et al., 2010, 2011). Glycogenolysis produces
glucose-6-phosphate (Fig. 2), which when elevated inhibits hexokinase
and thereby inhibits glucose utilization. Glucose-6-phosphate that is
generated selectively from glycogen in astrocytes could, if not rapidly
consumed, selectively suppress astrocyte glucose utilization and
thereby preserve extracellular glucose for neuronal consumption.
Although these concepts have gained wide support, experimental
observations suggest than glucose availability is rarely if ever rate-
liming for brain energy metabolism, even for short time intervals. The
concentration of glucose in brain is normally 1–2 mM (de Graaf et al.,
2001; Gruetter et al., 1998; Shestov et al., 2011), and reductions in this
concentration cannot significantly limit glucose utilization rate unless
they approach the hexokinase Km for glucose, which is 0.03 - 0.3 mM
(Wilson, 2003). At a resting glucose utilization rate of 0.25 μmol /g
/min, (Dienel, 2019),a brain glucose concentration of 1 mM glucose (1
μmol /g) would supply local brain metabolism for roughly 3 min by
oxidative metabolism, or about 15 s by anaerobic metabolism. This
appraisal matches experimental observations. The classic study by
Silver and Ericińska found that spreading depression, which causes
nearly simultaneous bursting of neurons at its wave front and thus
approximates the maximal rate of brain energy demand, reduced ex-
tracellular glucose concentrations by only 25 % (Silver and Erecinska,
1994). Sustained pentylenetetrazole-induced status epilepticus simi-
larly produces only minor reductions in brain glucose concentration,
excluding settings in which cerebral blood flow is impaired
(Folbergrova et al., 1985; Ingvar et al., 1984; McCandless et al., 1987).
These findings are also consistent with the observation that the max-
imum rate of glucose transport into brain is more than twice the
maximum rate of glucose utilization (de Graaf et al., 2001; Shestov
et al., 2011). Moreover, functional MRI studies show that neither total
cerebral blood flow nor local activity-induced increases in cerebral
blood flow are attenuated by large (3-fold) elevation in blood glucose
concentration (Gruetter et al., 2000), as would be expected if activity-
induced local increases in cerebral blood flow were required to prevent
insufficient glucose delivery.
In summary, the 1−2 mM glucose concentration in brain is itself a
large buffer against transient mismatches between glucose supply and
demand, measured changes in brain glucose content show only small
reductions even with supra-physiological brain activity, and the mea-
sured capacity to transport glucose into brain far exceeds brain capacity
to utilize glucose. These in vivo experimental findings argue against the
idea that normal brain activity can drive local glucose concentrations
below levels required to fuel neuronal or astrocyte function even for
very brief time intervals, and suggest instead that glycogen must serve a
purpose other than (or in additional to) a local glucose reserve. This
suggestion is supported by studies using cell culture preparations, in
which glucose is always available in far excess of need. In cultured
astrocytes, the maximal rate of energy-dependent K+ uptake is reduced
by pharmacological inhibition of glycogen phosphorylase (Xu et al.,
2013). Similarly, glycogen phosphorylase inhibition reduces miniature
excitatory and inhibitory post-synaptic currents in neurons cultured
with astrocytes (but not in neurons alone) despite ample glucose in the
culture medium (Kaczor et al., 2015; Mozrzymas et al., 2011).
4. Current concepts of muscle glycogen function
Skeletal muscle fiber types can be classified as Type 1 “red” or Type
2 “white”, with the red fibers containing more mitochondria and white
fibers containing more glycogen (Nielsen et al., 2011). At the sub-
cellular level, muscle glycogen is concentrated within and between
individual myofibrils, which are the contractile elements and major
ATP consuming sites (Ortenblad and Nielsen, 2015). Glycogen is con-
sumed during muscle activity and is re-synthesized from blood-borne
glucose between muscle contractions (Nielsen et al., 2011; Shulman
and Rothman, 2001). During very rapid or sustained muscle activity,
glycogen consumption outpaces synthesis and is eventually depleted.
It is generally presumed that muscle glycogen is metabolized to
augment circulating glucose to fuel the energy demand during the brief
periods (10–40 milliseconds) of high ATP demand associated with in-
dividual myocyte contractions (Chin and Allen, 1997; Shulman and
Rothman, 2001). However, glucose concentrations in muscle are in the
millimolar range, far too high to be consumed in sub-second intervals.
Moreover, muscle glucose content increases rather than decreases with
exercise, as a result of increased blood flow (Hamrin et al., 2011;
MacLean et al., 1999; Rosdahl et al., 1993; Sahlin, 1990). Although
sustained muscle contraction can reduce the flow of blood through
contracting muscle, this reduction is incomplete even with intense and
prolonged contractions (Lanza et al., 2005; McNeil et al., 2015;
Wigmore et al., 2006). Even in the absence of glucose, the 20–25mM
concentration of phosphocreatine (PCr) in muscle would be sufficient to
maintain muscle ATP levels for at least several seconds (Baker et al.,
2010; Bogdanis et al., 1996; Funk et al., 1989; Meyer, 1988) (see Text
Box).
Alternatively, glycogen might be metabolized to produce glucose-6-
phosphate more quickly than it can be produced from free glucose, as
the maximal flux through glycogen phosphorylase substantially exceeds
maximal flux through hexokinase in mammalian skeletal muscle
(Suarez et al., 1997). However, an accelerated production of glucose-6-
phosphate would not significantly increase the rate of glycolytic ATP
production because it is the downstream phosphofructokinase and
glyceraldehyde-3-phosphate dehydrogenase steps that are rate-limiting
for glycolytic ATP production, rather than glucose-6-phosphate avail-
ability (Kobayashi and Neely, 1979; Tanner et al., 2018). There is no
evidence that glycogen in muscle is metabolized in one cell to fuel
activity in a neighboring cell, as has been proposed for glycogen in
brain astrocytes.
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All of these observations argue against the idea that muscle gly-
cogen serves as local glucose reserve to bridge brief mismatches be-
tween blood glucose delivery and glucose demand. But most con-
clusively, studies using “skinned” (permeabilized) muscle fibers showed
that muscle fibers depleted of glycogen are unable to attain maximal con-
tractile force even when perfused with excess glucose, phosphocreatine
(PCr), and ATP (Stephenson et al., 1999), thereby definitively estab-
lishing that muscle glycogen must have functions other than simply a
glucose store. Importantly, these authors also noted that glycogen re-
presents a sizeable sink for Pi in contracting muscle, and this provides a
biochemical link between glycogen and muscle fatigue.
Muscle fatigue is physiologically defined as a progressive decline in
contractile force that largely recovers after rest (Allen et al., 2008).
Fatiguing muscle also has reduced efficiency, i.e. produces less force per
unit of metabolic substrate consumed (Broxterman et al., 2017;
Gorostiaga et al., 2010). Muscle fatigue correlates well with glycogen
depletion (Allen et al., 2008; Ortenblad and Nielsen, 2015); however,
the primary biochemical factor causing muscle fatigue is not reduced
ATP, but rather elevated inorganic phosphate (Pi) (Baker et al., 1993;
Cooke et al., 1988; Miller et al., 1993). Elevated Pi concentrations ac-
tively suppress muscle activity, in part by inhibiting the release of
calcium from the sarcoplasmic reticulum that triggers muscle fiber
contraction (Allen et al., 2002; Allen and Trajanovska, 2012). Thus, the
studies by skinned muscle fiber studies by Stephenson and colleagues
described above suggest that Pi sequestration may be the primary
function of glycogen metabolism in exercising muscle.
5. A thermodynamic function of glycogen metabolism
The capacity of cells to do work is determined not only by their
levels of ATP, but also by the amount of energy obtained from each
molecule of ATP consumed (ΔG’ATP). The ΔG’ATP in mammalian cells is
usually near -55 kJ / mol. The more negative the value of ΔG’ATP, the
more energy obtained from each molecule of ATP hydrolyzed to ADP.
When the ΔG’ATP rises (becomes less negative), ATP hydrolysis pro-
duces less energy. It is thus important that cells maintain ΔG’ATP in
order to maximize both work capacity and work efficiency (i.e. work
performed per substrate consumed). Omitting the terms for H+, Mg2+
and H2O for clarity (Alberty, 1969; Manchester, 1989), the simplified
equation for ATP hydrolysis is
ATP → ADP + Pi (1)
and the corresponding equation for the free energy (ΔG’) for ATP
hydrolysis is
ΔG’ATP = ΔG°’ATP + RT ln([ADP]∙[Pi] / [ATP]) (2)
where ΔG⁰’ATP is the free energy of ATP hydrolysis under defined
standard conditions (1 M concentrations of all reactants and products),
R is the gas constant, ln is the natural logarithm, and T is temperature.
(See (Iotti et al., 2005) for a more complete description). The equation
states that the amount of energy derived from ATP is influenced by the
local concentrations of ADP and Pi. When the ratio of [ADP] ∙ [Pi] /
[ATP] is increased, the value of ΔG’ becomes less negative and less
energy is obtained from ATP consumption.
During very rapid energy demand, the rate of ATP consumption can
exceed capacity for ATP regeneration. This affects cell energetics in two
ways: it reduces ATP availability, and by elevating ADP and Pi it in-
creases ΔG’ATP. Of these two, it is the increase in ΔG’ATP that is most im-
mediately significant. This is because the intracellular ATP concentration
is normally 3–10 mM, and reductions in ATP concentration do not
significantly limit the velocity of ATP - consuming enzymes unless they
approach the enzyme ATP Km values. These values are below 20 μM for
both Na+/K+ ATPase and myosin ATPase (Hackney and Clark, 1985;
Pilotelle-Bunner et al., 2008). By contrast, any elevation in ΔG’ATP
immediately reduces the amount of energy derived from ATP
hydrolysis. This particularly affects enzymes that operate near ther-
modynamic equilibrium with respect to ΔG’ATP, which include both
Na+/K+ ATPase and myosin ATPase (Astumian, 2010; Ventura-Clapier
et al., 1987; Wagoner and Dill, 2019; Wallimann, 1994).
The effect of Pi elevations on ΔG’ATP. can be substantial not only in
the immediate vicinities of ATP hydrolysis, but also at the whole-cell
level. Whole-cell Pi concentrations in muscle rise from about 1 mM to
above 5 mM during strenuous exercise (Bogdanis et al., 1996, 1998;
Gaitanos et al., 1993; Sahlin et al., 1997), and Pi elevation is the pri-
mary biochemical cause of both muscle fatigue and reduced efficiency,
as noted above. Crucially, the glycogen phosphorylase reaction at-
tenuates the rise in Pi.
Pi + glycogenn → glycogenn-1 + glucose-1-phosphate (3)
By removing Pi from the cytosol, glycogen utilization buffers ele-
vations in Pi that would otherwise reduce the amount of energy ob-
tained from ATP utilization.
This effect of Pi sequestration on ΔG’ATP might be spatially and
temporally limited if the Pi bound as glucose-1-phosphate were rapidly
liberated back to the cytosol. However, measurements from actively
exercising muscle show that most of the Pi remains sequestered as
millimolar concentrations of phosphorylated glycolytic intermediates,
primarily glucose-6-phosphate, until exercise ends (Bendahan et al.,
1990, 1992; Bogdanis et al., 1996, 1998; Gaitanos et al., 1993;
Kappenstein et al., 2013).
In principle, Pi sequestration as phosphorylated glycolytic inter-
mediates could also be accomplished by metabolizing glucose, rather
than glycogen. Pi sequestration in that case does not occur in the first,
hexokinase step of glycolysis, but does occur after accounting for sub-
sequent ATP re-synthesis, as shown below in the summed reactions of
glycolysis.
+ ++ +++ + +
glucos e ATP glucos e 6 phosphate ADP
glucos e 6 phosphate 2Pi 3ADP
3ATP 2pyruvate
net: glucos e 2Pi 2ADP 2ATP 2pyruvate (4)
However, a direct comparison between use of glycogen vs glucose as
the substrate shows that glycogen metabolism removes a net one more
Pi molecule per glucose moiety consumed and produces one less mo-
lecule of ADP. + +
+ + ++ + + +
glycogen Pi  glycogen  glucose 1 phosphate
glucose 1 phosphate  glucose 6 phosphate
glucose 6 phosphate  3ADP  2Pi  3ATP  2 pyruvate




Thus, relative to free glucose utilization, glycogen utilization better
maintains ΔG’ATP by removing Pi from the cytosol in its initial (fastest)
step, by removing a net of 1 more Pi through glycolysis, and by pro-
ducing one less ADP per glucose residue metabolized. We propose that
these thermodynamic advantages are crucial during rapid ATP hydro-
lysis, such that the immediate advantage gained in maximizing ΔG’ATP
more than offsets the overall ATP cost of cycling glucose through gly-
cogen polymer.
5.1. Coupled effects of glycogen and phosphocreatine on ΔG’ATP
The ΔG’ATP can also maintained in part by creatine kinase reaction,
which limits ADP elevations while at the same time regenerating ATP.
PCr + ADP ↔ ATP + Cr (6)
This utilization of phosphocreatine (PCr) is generally considered to
be a strategy for maintaining ATP concentrations when (or where)
maximal ATP synthesis falls short of demand. However, this reaction
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has a far greater relative effect on ADP levels (and thus on ΔG’ATP) than
on ATP levels because the ratio of ADP : ATP is normally very low
(Wallimann, 1994). It has therefore been proposed that the primary
function of PCr under steady state conditions, i.e. no net change in ATP
or PCr, is to maintain ΔG’ATP at sites of ATP hydrolysis by buffering the
local rise in ADP (Saks et al., 2007; Ventura-Clapier et al., 1987;
Wallimann, 1994). However, the effects of PCr metabolism on ΔG’ATP
become more complex during net PCr consumption. Under these con-
ditions, the phosphate moieties initially bound in PCr are eventually
released as free Pi.
(7)
Given that muscle cells at rest contain over 25 mM PCr and less than
2 mM Pi, complete consumption of PCr with strenuous exercise could
lead to>10-fold increase in free Pi, with a commensurate effect on
ΔG’ATP (see Table 2). Under these conditions, glycogen utilization can
work in tandem with PCr to preserve ΔG’ATP by limiting the rise in both
ADP and Pi that would otherwise occur (Fig. 3).
(8)
It is thus noteworthy that both astrocytes and skeletal myocytes
contain high levels of cytosolic phosphocreatine (Lowe et al., 2013;
Manos et al., 1991; Zhang et al., 2014), along with high levels of gly-
cogen.
5.2. Importance of glycogen metabolism for maintaining ΔG’ATP in muscle
Published measurements of metabolite concentration changes in
exercising muscle permit a quantitative appraisal of the effect of gly-
cogen utilization on ΔG’ATP at the whole-cell level. As shown in Table 2,
phosphate sequestration in glycogen-derived metabolites can be esti-
mated to reduce the relative change in ΔG’ATP by roughly 40 % (from
9.2 to 5.6 kJ /mol) during muscle exertion that nearly depletes PCr.
This estimate is based on bulk tissue measurements, which necessarily
underestimate the magnitude of local subcellular changes. Pi elevations
in the immediate vicinity of rapid ATP - consuming processes are likely
Table 2
Estimated effect of glycogen on exercise - induced changes in whole-cell ΔG’ATP.
Glycogen (mM glucose
equivalents)
PCr (mM) ATP (mM) ADP (mM) Pi (mM) ΔG’ATP (kJ/
mol)
Change in ΔG’ATP relative to
rest
Measured: At rest 114 26.32 9.45 1.19 1.01 −53.6 - - -
Measured: End-exercise 80 4.41 6.86 1.37 5.67 −48.0 5.6 kJ/mol (10.5 %)
Estimated: End-exercise in the absence of
glycogen
- - - 4.41 6.86 1.37 22.9 −44.4 9.2 kJ/mol (17.2 %)
The measured metabolite values at rest and end-exercise are from biopsy studies of human quadriceps muscle: glycogen, PCr, ATP, and Pi from (Bogdanis et al.,
1996), and ADP from (Sahlin et al., 1997). Similar values are reported in other studies (Bogdanis et al., 1998; Gaitanos et al., 1993). ΔG’ATP values are calculated as
ΔG°’ATP + RT ln ([ADP]∙[Pi] / [ATP]), using -30.5 kJ / mol for ΔG°’ATP and using 2.58 kJ / mol for RT at 37 °C. For simplicity, the calculated ΔG’ATP values do not
account for the relatively smaller effects of Mg2+ and H+ binding to the metabolites (Iotti et al., 2005). The calculations also do not account for possible changes in
the ratios of free : bound metabolites during exercise. For the estimated values in the absence of glycogen it is assumed that net consumption of PCr would produce an
equimolar amount of Pi. It is also assumed that rates of ATP and PCr consumption would be unaffected by the absence of glycogen, but in actual muscle the rates of
PCr consumption and ATP turnover would be suppressed by increased Pi (as occurs in McArdle disease). The rise in muscle Pi during strenuous exercise reduces the
energy (ΔG’ATP) that can be obtained from ATP hydrolysis. Pi elevations in vigorously exercising muscle are normally buffered by sequestration in glycogen-derived
hexose monophosphates and other glycolytic intermediates (Bendahan et al., 1990, 1992; Bogdanis et al., 1996, 1998; Gaitanos et al., 1993; Kappenstein et al.,
2013), as illustrated in Fig. 3. In the absence of glycogen, the resulting greater increase in Pi correspondingly increases ΔG’ATP and decreases work efficiency and
capacity.
Fig. 3. Combined effects of glycogen and phosphocreatine on
ΔG’ATP. The amount of energy obtained from the hydrolysis of
each ATP molecule (ΔG’ATP) is reduced by elevations in either
ADP or Pi. a) At steady state, ATP hydrolysis is matched by ATP
re-synthesis through glycolysis and oxidative phosphorylation,
with no net change in ATP or ADP concentrations. b) When
ATP consumption exceeds the maximal rate of ATP re-synth-
esis, the resulting elevations in ADP and Pi reduce the amount
of energy that can be obtained from each molecule of ATP. c)
Cell types that contain cytosolic phosphocreatine (PCr) can
consume PCr to convert ADP into ATP, thereby suppressing the
rise in ADP. However, the effect of this ADP buffering on
ΔG’ATP is offset by a further increase in Pi as phosphate moieties
in the newly formed ATP are subsequently released by ATP
hydrolysis. Resting muscle contains approximately 26 mM PCr,
9 mM ATP, 1 mM ADP, and 1 mM Pi, such that complete
consumption of PCr could increase Pi by over 20-fold (see
Table 2). d) Glycogen metabolism to glucose-1-phosphate (G-1-
P) removes Pi from the cytosol, thereby minimizing the effect of
Pi on ΔG’ATP. G-1-P is in turn metabolized to glucose- 6-phos-
phate and other phosphorylated intermediates. In exercising
muscle, phosphate remains trapped in these intermediates until
ATP consumption rate falls below ATP synthesis rate and PCr
levels are normalized.
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faster and larger than estimated by the bulk tissue measurements, with
a proportionately greater impact of Pi sequestration on subcellular
ΔG’ATP values. The increased efficiency provided by glycogen Pi se-
questration also means that proportionately less ATP and energy sub-
strates need be consumed to perform the same amount of work. To
place these effects in context, even very small changes in work capacity
can translate to significant differences in competitive advantage; e.g.
the difference in the 100-meter sprint times between Olympic gold
medalists and fourth place finishers is typically less than 1.5 %.
The thermodynamic effect of glycogen metabolism is also evidenced
in McArdle disease, in which genetic deficiency in muscle glycogen
phosphorylase (PGYM) prevents the utilization of skeletal muscle gly-
cogen (Nogales-Gadea et al., 2016). Individuals with McArdle disease
have no difficulty with moderate levels of exercise such as walking, but
develop early onset muscle fatigue with strenuous exercise, followed by
muscle cramps (sustained, electrically silent contractions) and myocyte
disruption if exercise is continued. Importantly, the ATP concentration
in exercising muscle of these individuals does not fall significantly
lower than in normal subjects (or in resting muscle), but Pi con-
centrations rise faster and further than in normal muscle (Bendahan
et al., 1992; Lofberg et al., 2001; Malucelli et al., 2011). This rise can be
directly attributed to the absence of phosphate binding in glycogen-
derived intermediates because, in contrast to normal muscle, the rise in
Pi is nearly equimolar with the fall in PCr, and because there is no
increase in phosphorylated glycolytic intermediates as in normal
muscle (Bendahan et al., 1990, 1992; Rowland et al., 1965). These
observations also indicate that glycogen is by far the primary me-
chanism used by myocytes to buffer Pi elevations.
The overall efficiency of muscle contraction – i.e. the work pro-
duced relative to the energy substrate consumed – is reduced in
McArdle disease (O’Dochartaigh et al., 2004). Correspondingly, the
calculated ΔG’ATP in McArdle disease muscle is less negative (lower)
after exercise than in normal muscle (Malucelli et al., 2011). McArdle
disease muscle also forms inosine and ammonia with even moderate
exercise (Kazemi-Esfarjani et al., 2002). Inosine and ammonia are
products of AMP degradation, and their elevation after exercise is in-
dicative of AMP formed by activation of adenylate kinase (Tullson and
Terjung, 1991; see Text Box). While the adenylate kinase reaction
generates only small increases in ATP, it generates a proportionately far
greater reduction in ADP (given that ATP> >ADP), and thereby
serves to maintain the normal ΔG’ATP. Activation of the adenylate ki-
nase reaction thus illustrates the biological importance of maintaining
muscle ΔG’ATP, because this incurs the unsustainable cost of depleting
the total adenylate pool as (ATP + ADP + AMP) as AMP is degraded.
An additional feature of McArdle disease has long been un-
explained: the absence of any net increase in lactate or H+ production
(aerobic glycolysis) in exercising muscle (Bendahan et al., 1992;
Kazemi-Esfarjani et al., 2002; Lofberg et al., 2001), despite adequate
glucose delivery (Berger et al., 1975; Hamrin and Henriksson, 2008;
Hamrin et al., 2011; Henriksson and Knol, 2005; MacLean et al., 1999;
Rosdahl et al., 1993), and even with induced hyperglycemia (Haller and
Vissing, 2002; Lewis et al., 1985). Given that elevated Pi suppresses
muscle contraction (Allen et al., 2002; Allen and Trajanovska, 2012),
the failure to increase aerobic glycolysis may reflect a lack of metabolic
demand induced by elevated Pi, rather than impaired capacity of the
muscle fibers to increase use glucose utilization. This concept is sup-
ported by the strikingly attenuated increase in blood flow in exercising
McArdle disease muscle (Jehenson et al., 1995), an observation that is
difficult to explain except by reduced metabolic demand. Of interest,
there is evidence for increased epilepsy incidence in McArdle disease
(Mancuso et al., 2011), though otherwise there is no indication of brain
dysfunction. This is presumably because astrocytes normally express
the brain form of glycogen phosphorylase, PGYB, in addition to the
muscle PGYM form.
The importance of maintaining ΔG’ATP is most evident under ex-
treme conditions such as intense exercise and McArdle disease, but it is
relevant at all levels of energy metabolism to the extent that processes
operating at an elevated (less negative) ΔG’ATP must consume more
substrate to achieve equal amounts of work. Moreover, as demonstrated
with the skinned muscle fiber preparation, maximal force cannot be
achieved in the absence of glycogen even when glucose, PCr, and ATP
are available (Stephenson et al., 1999). Myosin ATPase is near ther-
modynamic equilibrium, meaning that the probability of forward
movement of the actin/myosin motor is at all times influenced by ex-
isting the ΔG’ATP (Astumian, 2010). This is similarly true of other AT-
Pases, including the Na+/K+ ATPases that drive transmembrane ion
transport in brain and other tissues (Ventura-Clapier et al., 1987;
Wagoner and Dill, 2019; Wallimann, 1994). By contrast, the functions
of these enzymes are minimally affected by the magnitude of changes in
ATP concentration that occur under physiological conditions.
5.3. Importance of glycogen metabolism for maintaining ΔG’ATP in brain
The functional effects of ΔG’ATP are more difficult to quantify in
brain than in muscle, where fiber contraction provides a convenient
read-out of work capacity, but evidence that glycogen metabolism is
also required for optimal bioenergetic efficiency in brain comes from
observations suggesting “glycolytic super-compensation” when gly-
cogen metabolism is blocked. Glycolytic super-compensation describes
an increase in glucose utilization above what is required to compensate
for an absence of glucose mobilization from glycogen (Walls et al.,
2009). Studies by Dienel and colleagues found that activity - induced
increase in glucose utilization in rat sensory cortex was further in-
creased by 1.7–2.9 fold by pharmacological inhibition of glycogen
phosphorylase (Dienel et al., 2007). While the proportion of glucose
consumed by astrocytes vs. neurons is uncertain, this result suggests a
reduction in brain energetic efficiency in the absence of glycogen
analogous to that observed in McArdle disease muscle (Malucelli et al.,
2011; O’Dochartaigh et al., 2004).
There has been a long-standing interest in why glycogen is localized
predominately to astrocytes rather than neurons. There has been less
focus on why astrocytes also contain more PCr than neurons, but the
answers to both questions may be gleaned by extrapolation from ske-
letal muscle. In muscle, PCr and glycogen are consumed during discrete
episodes during which demand for ATP exceeds myocyte capacity to
produce ATP. The thermodynamic role of glycogen as a Pi sink is par-
ticularly important in cells that have high levels of cytosolic PCr, be-
cause the net consumption of PCr during energy demand leads in-
directly to equimolar release of free Pi (Fig. 3). Brain, like muscle,
responds to rapid increases in energy demand in part by net con-
sumption of PCr (Jost et al., 2002; Mora et al., 1991). While all cell
types contain the ubiquitous mitochondrial creatine kinase, only certain
tissues are enriched in cytosolic creatine kinase and cytosolic PCR.
These tissues are skeletal muscle, which expresses the CKm isoform;
brain, which expresses the CKb isoform; and heart, which expresses
both isoforms. In brain, CKb is expressed at much higher levels in as-
trocytes than in neurons (Lowe et al., 2013; Manos et al., 1991; Zhang
et al., 2014). The co-enrichment of cytosolic PCr and glycogen in as-
trocytes can thereby permit their coupled effects on ΔG’ATP during in-
tervals of rapid energy demand (Fig. 3).
Episodic energy demands on astrocytes are presumably caused by
episodic activity of neighboring neurons, as supported by observations
summarized in section 2.1. Glutamate is the primary excitatory neu-
rotransmitter in mammalian brain, and it is removed from the extra-
cellular space almost exclusively by re-uptake into astrocytes (Anderson
and Swanson, 2000). Astrocytes maintain a glutamate concentration
gradient of roughly 10,000:1 across their cell membranes through the
activity of sodium-dependent glutamate transporters, which consume
more than 2 ATP per molecule of glutamate transported against this
gradient. It is thus significant that glycogen phosphorylase has been
identified in a macromolecular assembly with the astrocyte glutamate
transporter, GLT-1 (Genda et al., 2011). Neuronal post-synaptic
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depolarizations and action potentials also release K+ into small extra-
cellular compartments, requiring immediate local, energy dependent
K+ uptake by astrocytes, which has been calculated to require an even
greater astrocytic energy expenditure than glutamate uptake (DiNuzzo
et al., 2017). Analogous to skeletal muscle, these demands on astrocytes
are variable and episodic.
This alone does not, however, provide a clear explanation as to why
neurons do not contain glycogen or high cytosolic PCr levels, given that
neurons have higher energy requirements than astrocytes on average
(Harris et al., 2012), and often exhibit short bursts of activity. However,
these activity bursts may not necessarily require corresponding episodic
bursts of neuronal energy metabolism. Measurements from cortical
slices show that burst activation of neurons produces a small decrement
in intracellular astrocyte glucose content, as expected, but no detectable
decrease in intracellular neuronal glucose content (Mächler et al.,
2019). The differing response by neurons may follow from the elec-
trogenic distribution of neuronal repolarization over the entire neu-
ronal surface area. The energy cost of neuronal action potentials and
depolarizations occurs with the active ion transport required for
membrane repolarization. Since the membrane potential is maintained
over the entire surface of the neuron, the energy demand induced by
repolarization after intervals of neuronal activity is distributed both
spatially and temporally. By contrast, the uptake of glutamate and K+
by astrocytes is only minimally electrogenic (Anderson and Swanson,
2000), and requires immediate, local activation of Na+/ K+ ATPase in
order to maintain the local transmembrane Na+ gradient that drives
active transport. It should also be noted that evidence from cell culture
and other studies indicate that mammalian neurons do contain some
glycogen (Duran et al., 2019; Pfeiffer-Guglielmi et al., 2014; Saez et al.,
2014). In fact, some neuronal populations contain histochemically de-
monstrable glycogen comparable to that present in astrocytes (Borke
and Nau, 1984; Oe et al., 2016; Saez et al., 2014). It would be of interest
to know whether the activity pattern of these neuronal populations is
distinctive.
A second reason that astrocytes rather than neurons require gly-
cogen and PCr may stem from the unique aspects of astrocyte anatomy.
Roughly 80 % of astrocyte surface area consists of threadlike filopodia
(∼0.2 μm wide) and equally thin, sheet-like lamellipodia that ensheath
neuronal elements (Grosche et al., 1999; Hertz et al., 2007). These thin
processes perform most astrocyte active transport, but are too narrow to
contain mitochondria. Reduced mitochondrial density or proximity
renders it easier for ATP consumption to outstrip ATP synthesis in these
fine processes. Moreover, the spatial constraints of these processes may
also limit the rate at which ADP and Pi can diffuse away from sites of
ATP consumption, thereby increasing the need for local buffering.
6. Summary
There is little question that glycogen can serve as an emergency
energy store in brain, that astrocyte glycogen utilization can spare
glucose for neuronal use, and that lactate generated by astrocyte gly-
cogenolysis can subsequently be used by neurons (or other cells) for
oxidative energy metabolism. There is similarly little question that
glycogen in muscle can serve as a local glucose reserve. However, these
functions do not adequately account for several other aspects of gly-
cogen metabolism in brain and muscle: specifically that 1) in both tis-
sues, glycogen is metabolized even when glucose is available, despite
the net ATP cost of glycogen use; (2) in both tissues, evidence suggests a
reduced energetic efficiency in the absence of glycogen; (3) in both
tissues, glycogen is co-localized with elevated levels of cytosolic PCr;
and (4) muscle deficient in glycogen phosphorylase (McArdle disease)
fails to increase glycolytic metabolism or local blood flow, but instead
activates the adenylate kinase reaction to lower ADP levels. Each of
these aspects of glycogen metabolism can be understood by the ther-
modynamic considerations presented here. The thermodynamic view
holds that it is equally or more important for cells to maintain the
amount of energy derived from ATP hydrolysis as to maintain ATP
concentrations, because cells with less negative ΔG’ATP have reduced
maximal work capacity and must consume more ATP to do equivalent
work. ΔG’ATP is increased when ADP or Pi increase, and this can occur
in cells (or in subcellular domains) that must transiently utilize ATP
faster that it can be regenerated. The coupled metabolism of glycogen
and PCr buffers elevations in Pi and ADP, and thereby maintains a
maximal energy yield from ATP hydrolysis. This effect may be parti-
cularly important in subcellular domains such as thin astrocyte pro-
cesses, where simple diffusion may be insufficient to quickly dissipate
local Pi and ADP elevations during intervals of rapid ATP consumption.
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